Literature DB >> 23323744

Myosin-binding protein C DNA variants in domestic cats (A31P, A74T, R820W) and their association with hypertrophic cardiomyopathy.

M Longeri1, P Ferrari, P Knafelz, A Mezzelani, A Marabotti, L Milanesi, G Pertica, M Polli, P G Brambilla, M Kittleson, L A Lyons, F Porciello.   

Abstract

BACKGROUND: Two mutations in the MYBPC3 gene have been identified in Maine Coon (MCO) and Ragdoll (RD) cats with hypertrophic cardiomyopathy (HCM).
OBJECTIVE: This study examined the frequency of these mutations and of the A74T polymorphism to describe their worldwide distribution and correlation with echocardiography. ANIMALS: 1855 cats representing 28 breeds and random-bred cats worldwide, of which 446 underwent echocardiographic examination.
METHODS: This is a prospective cross-sectional study. Polymorphisms were genotyped by Illumina VeraCode GoldenGate or by direct sequencing. The disease status was defined by echocardiography according to established guidelines. Odds ratios for the joint probability of having HCM and the alleles were calculated by meta-analysis. Functional analysis was simulated.
RESULTS: The MYBPC3 A31P and R820W were restricted to MCO and RD, respectively. Both purebred and random-bred cats had HCM and the incidence increased with age. The A74T polymorphism was not associated with any phenotype. HCM was most prevalent in MCO homozygote for the A31P mutation and the penetrance increased with age. The penetrance of the heterozygote genotype was lower (0.08) compared with the P/P genotype (0.58) in MCO. CONCLUSIONS AND CLINICAL IMPORTANCE: A31P mutation occurs frequently in MCO cats. The high incidence of HCM in homozygotes for the mutation supports the causal nature of the A31P mutation. Penetrance is incomplete for heterozygotes at A31P locus, at least at a young age. The A74T variant does not appear to be correlated with HCM.
Copyright © 2013 by the American College of Veterinary Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23323744      PMCID: PMC3602388          DOI: 10.1111/jvim.12031

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  37 in total

1.  Salt bridge stability in monomeric proteins.

Authors:  S Kumar; R Nussinov
Journal:  J Mol Biol       Date:  1999-11-12       Impact factor: 5.469

2.  Nomenclature for the description of human sequence variations.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Genet       Date:  2001-07       Impact factor: 4.132

Review 3.  Hypertrophic cardiomyopathy in cats--it used to be so simple!

Authors:  J Haggstrom
Journal:  J Feline Med Surg       Date:  2003-04       Impact factor: 2.015

4.  Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors.

Authors:  S J Hubbard; S F Campbell; J M Thornton
Journal:  J Mol Biol       Date:  1991-07-20       Impact factor: 5.469

5.  Comparative echocardiographic and clinical features of hypertrophic cardiomyopathy in 5 breeds of cats: a retrospective analysis of 344 cases (2001-2011).

Authors:  E Trehiou-Sechi; R Tissier; V Gouni; C Misbach; A M P Petit; D Balouka; C Carlos Sampedrano; M Castaignet; J-L Pouchelon; V Chetboul
Journal:  J Vet Intern Med       Date:  2012-03-23       Impact factor: 3.333

Review 6.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

7.  Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine.

Authors:  W P Thomas; C E Gaber; G J Jacobs; P M Kaplan; C W Lombard; N S Moise; B L Moses
Journal:  J Vet Intern Med       Date:  1993 Jul-Aug       Impact factor: 3.333

8.  Comparative protein modelling by satisfaction of spatial restraints.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

9.  Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.

Authors:  W Kabsch; C Sander
Journal:  Biopolymers       Date:  1983-12       Impact factor: 2.505

Review 10.  Myosin binding protein C: structural abnormalities in familial hypertrophic cardiomyopathy.

Authors:  Cecily E Oakley; Brett D Hambly; Paul M G Curmi; Louise J Brown
Journal:  Cell Res       Date:  2004-04       Impact factor: 25.617

View more
  15 in total

Review 1.  The genetic basis of hypertrophic cardiomyopathy in cats and humans.

Authors:  Mark D Kittleson; Kathryn M Meurs; Samantha P Harris
Journal:  J Vet Cardiol       Date:  2015-12       Impact factor: 1.701

2.  A feline orthologue of the human MYH7 c.5647G>A (p.(Glu1883Lys)) variant causes hypertrophic cardiomyopathy in a Domestic Shorthair cat.

Authors:  Tom Schipper; Mario Van Poucke; Laurien Sonck; Pascale Smets; Richard Ducatelle; Bart J G Broeckx; Luc J Peelman
Journal:  Eur J Hum Genet       Date:  2019-06-04       Impact factor: 4.246

3.  Serum microRNA profiles in cats with hypertrophic cardiomyopathy.

Authors:  K Weber; N Rostert; S Bauersachs; G Wess
Journal:  Mol Cell Biochem       Date:  2015-01-09       Impact factor: 3.396

Review 4.  Animal and in silico models for the study of sarcomeric cardiomyopathies.

Authors:  Dirk J Duncker; Jeroen Bakkers; Bianca J Brundel; Jeff Robbins; Jil C Tardiff; Lucie Carrier
Journal:  Cardiovasc Res       Date:  2015-01-18       Impact factor: 10.787

5.  Genetic epidemiology of blood type, disease and trait variants, and genome-wide genetic diversity in over 11,000 domestic cats.

Authors:  Heidi Anderson; Stephen Davison; Katherine M Lytle; Leena Honkanen; Jamie Freyer; Julia Mathlin; Kaisa Kyöstilä; Laura Inman; Annette Louviere; Rebecca Chodroff Foran; Oliver P Forman; Hannes Lohi; Jonas Donner
Journal:  PLoS Genet       Date:  2022-06-16       Impact factor: 6.020

6.  The A31P missense mutation in cardiac myosin binding protein C alters protein structure but does not cause haploinsufficiency.

Authors:  Sabine J van Dijk; Kristina Bezold Kooiker; Stacy Mazzalupo; Yuanzhang Yang; Alla S Kostyukova; Debbie J Mustacich; Elaine R Hoye; Joshua A Stern; Mark D Kittleson; Samantha P Harris
Journal:  Arch Biochem Biophys       Date:  2016-01-09       Impact factor: 4.013

7.  Platelet activation in cats with hypertrophic cardiomyopathy.

Authors:  F Tablin; T Schumacher; M Pombo; C T Marion; K Huang; J W Norris; K E Jandrey; M D Kittleson
Journal:  J Vet Intern Med       Date:  2014-02-24       Impact factor: 3.333

8.  Investigations into the Sarcomeric Protein and Ca2+-Regulation Abnormalities Underlying Hypertrophic Cardiomyopathy in Cats (Felix catus).

Authors:  Andrew E Messer; Jasmine Chan; Alex Daley; O'Neal Copeland; Steven B Marston; David J Connolly
Journal:  Front Physiol       Date:  2017-06-08       Impact factor: 4.566

Review 9.  A One Health Approach to Hypertrophic Cardiomyopathy.

Authors:  Yu Ueda; Joshua A Stern
Journal:  Yale J Biol Med       Date:  2017-09-25

10.  Mucopolysaccharidosis VI in cats - clarification regarding genetic testing.

Authors:  Leslie A Lyons; Robert A Grahn; Francesca Genova; Michela Beccaglia; John J Hopwood; Maria Longeri
Journal:  BMC Vet Res       Date:  2016-07-02       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.